<DOC>
	<DOC>NCT00974571</DOC>
	<brief_summary>This study will assess the ability of montelukast to improve the signs and symptoms of perennial allergic rhinitis compared to placebo. Cetirizine is included in the study as an active control.</brief_summary>
	<brief_title>Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient has a documented clinical history of perennial allergic rhinitis Patient is a nonsmoker Patient is in good general health Patient is hospitalized Patient is a woman who is &lt;8 weeks postpartum or is breastfeeding Patient is a current or past abuser of alcohol or illicit drugs</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>